Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination Against SARS-Cov2 in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.

NCT04970550 is registered in ClinicalTrials.gov with Hopital Nord Franche-Comte as lead sponsor.

NCT NCT04970550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04970550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination Against SARS-Cov2 in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.
Lead sponsor
Hopital Nord Franche-Comte
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
November 30, 2021
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis, spondyloarthritis